Aim for participants will be to quickly new antimicrobial therapies to treat chronic respiratory infections
News
PBD Biotech reveals vital update to TB test
Lyophilized PCR reaction bead reduces the cost of transport and extends shelf life for the test
Owlstone Medical collaborates with Bicycle Therapeutics
Duo team up for the development of antigen-targeted probes for early cancer detection
Immutep reveals initiation of pivotal Efti study
The clinical trial also involves paclitaxel in the treatment of metastatic breast cancer
Acesion announces positive atrial fibrillation study
Candidate AP30663 is an inhibitor for the conversion of atrial fibrillation to a normal sinus rhythm
Vygon monitors provide improvement for ovarian cancer patients
Norfolk and Norwich University Hospitals have been using two Mostcare Up devices since 2019
IIH headaches could be treated with exenatide
The type 2 diabetes therapy is being tested on patients in a phase 2 clinical trial
ICON and LEO Pharma join forces on clinical trial mission
Collaboration will concentrate on launching and running studies within medical dermatology
AstraZeneca’s IMFINZI improves lung cancer survival
Positive results emerge from AEGEAN phase 3 trial for patients with resectable non-small cell lung cancer
FlyPharma Europe, Vienna – 2023 conference officially launched
FlyPharma Europe chose Vienna for its latest conference due to the growing presence of Austrian biotechnology and pharmaceutical manufacturing
Cancer Research UK reach agreement with UCB
The partnership will concentrate on the development of two investigational antibodies
New laboratory space for MSD at The Francis Crick Institute
Move represents the latest phase of preparation for the opening of MSD’s new UK Discovery Centre
Novo Nordisk weight-loss drug available across NHS
NICE has recommended the use of semaglutide alongside a reduced-calorie diet and exercise
Affibody and Chiesi Group partner to develop treatments
Collaboration will focus on innovative therapies for patients with a range of respiratory diseases
SkinBioTherapeutics’ AxisBiotix-Ps gains approval
Company’s skin health product poised for vital European market launch following success in the UK
